Skip to main content

Catalyst Calendar

Thu, Aug 6, 2026

1 updates

7:30 AM

Agenus Reports Second Quarter 2026 Results and Advances Phase 3 ROBBIN Trial of BOT+BAL in Neoadjuvant MSS Colon Cancer

agenusbio.com

Tue, Jul 28, 2026

1 updates

4:30 PM

Agenus to Provide Second Quarter 2026 Financial Report and Development Update

agenusbio.com

Fri, Jul 17, 2026

1 updates

10:28 AM

Agenus Announces Three BOT+BAL Presentations Spanning Neoadjuvant and Late-Line Colorectal Cancer and Advanced Sarcomas at ESMO 2026

agenusbio.com

Mon, Jul 13, 2026

1 updates

6:00 AM

Agenus Announces Oversubscribed Private Placement of Up to $340 Million to Advance Registrational ROBBIN Trial of Neoadjuvant BOT+BAL in MSS Colon Cancer

agenusbio.com

Mon, Jul 6, 2026

1 updates

7:30 AM

Agenus Reports Landmark BOT+BAL Data Showing 33% Three-Year Overall Survival in Refractory MSS Metastatic Colorectal Cancer Without Active Liver Metastases at ESMO GI 2026

Presentation / Abstractagenusbio.com

Thu, Jun 25, 2026

1 updates

7:00 AM

Agenus Announces Three-Year Survival Data from Phase 1b BOT+BAL Study in MSS Metastatic Colorectal Cancer to be Presented at ESMO GI 2026

Presentation / Abstract • Phase 1agenusbio.com

Tue, Jun 2, 2026

1 updates

4:30 PM

Agenus Announces Virtual 2026 Annual Shareholders Meeting

agenusbio.com